Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Silencing of suppressor of cytokine signaling 1 enhances the immunological effect of mucin 1-calreticulin-primed 4T1 cell-treated dendritic cells in breast cancer treatment.

Qin S, Gao Z, Liu Y, Liu C, Wang J, Zou LL.

Oncol Lett. 2018 Feb;15(2):1630-1638. doi: 10.3892/ol.2017.7477. Epub 2017 Nov 23.

2.

Synthetic bioreducible lipid-based nanoparticles for miRNA delivery to mesenchymal stem cells to induce neuronal differentiation.

Takeda YS, Wang M, Deng P, Xu Q.

Bioeng Transl Med. 2016 Aug 8;1(2):160-167. doi: 10.1002/btm2.10021. eCollection 2016 Jun.

3.

Nucleases as a barrier to gene silencing in the cotton boll weevil, Anthonomus grandis.

Almeida Garcia R, Lima Pepino Macedo L, Cabral do Nascimento D, Gillet FX, Moreira-Pinto CE, Faheem M, Moreschi Basso AM, Mattar Silva MC, Grossi-de-Sa MF.

PLoS One. 2017 Dec 20;12(12):e0189600. doi: 10.1371/journal.pone.0189600. eCollection 2017.

4.

A simple in vitro tumor chemosensitivity assay based on cell penetrating peptide tagged luciferase.

Yu T, Lin J, Zhao J, Huang W, Zeng L, Fang Z, Xu N.

PLoS One. 2017 Nov 10;12(11):e0186184. doi: 10.1371/journal.pone.0186184. eCollection 2017.

5.

Unlocking Endosomal Entrapment with Supercharged Arginine-Rich Peptides.

Najjar K, Erazo-Oliveras A, Mosior JW, Whitlock MJ, Rostane I, Cinclair JM, Pellois JP.

Bioconjug Chem. 2017 Dec 20;28(12):2932-2941. doi: 10.1021/acs.bioconjchem.7b00560. Epub 2017 Nov 13.

PMID:
29065262
6.

Induction of RNAi Responses by Short Left-Handed Hairpin RNAi Triggers.

Hagopian JC, Hamil AS, van den Berg A, Meade BR, Eguchi A, Palm-Apergi C, Dowdy SF.

Nucleic Acid Ther. 2017 Oct;27(5):260-271. doi: 10.1089/nat.2017.0686. Epub 2017 Sep 21.

PMID:
28933656
7.

Cytosolic delivery of siRNA by ultra-high affinity dsRNA binding proteins.

Yang NJ, Kauke MJ, Sun F, Yang LF, Maass KF, Traxlmayr MW, Yu Y, Xu Y, Langer RS, Anderson DG, Wittrup KD.

Nucleic Acids Res. 2017 Jul 27;45(13):7602-7614. doi: 10.1093/nar/gkx546.

8.

Investigating Engineered Ribonucleoprotein Particles to Improve Oral RNAi Delivery in Crop Insect Pests.

Gillet FX, Garcia RA, Macedo LLP, Albuquerque EVS, Silva MCM, Grossi-de-Sa MF.

Front Physiol. 2017 Apr 28;8:256. doi: 10.3389/fphys.2017.00256. eCollection 2017.

9.

PSMA-homing dsRNA chimeric protein vector kills prostate cancer cells and activates anti-tumor bystander responses.

Langut Y, Edinger N, Flashner-Abramson E, Melamed-Book N, Lebendiker M, Levi-Kalisman Y, Klein S, Levitzki A.

Oncotarget. 2017 Apr 11;8(15):24046-24062. doi: 10.18632/oncotarget.15733.

10.

SiRNA Crosslinked Nanoparticles for the Treatment of Inflammation-induced Liver Injury.

Tang Y, Zeng Z, He X, Wang T, Ning X, Feng X.

Adv Sci (Weinh). 2016 Sep 2;4(2):1600228. doi: 10.1002/advs.201600228. eCollection 2017 Feb.

11.

Building Cell Selectivity into CPP-Mediated Strategies.

Martín I, Teixidó M, Giralt E.

Pharmaceuticals (Basel). 2010 May 14;3(5):1456-1490. Review.

12.

Cell-Penetrating Peptides-Mechanisms of Cellular Uptake and Generation of Delivery Systems.

Trabulo S, Cardoso AL, Mano M, De Lima MC.

Pharmaceuticals (Basel). 2010 Mar 30;3(4):961-993. Review.

13.

Protein transduction therapy into cochleae via the round window niche in guinea pigs.

Takeda H, Kurioka T, Kaitsuka T, Tomizawa K, Matsunobu T, Hakim F, Mizutari K, Miwa T, Yamada T, Ise M, Shiotani A, Yumoto E, Minoda R.

Mol Ther Methods Clin Dev. 2016 Aug 17;3:16055. doi: 10.1038/mtm.2016.55. eCollection 2016.

14.

Functional peptides for siRNA delivery.

Tai W, Gao X.

Adv Drug Deliv Rev. 2017 Feb;110-111:157-168. doi: 10.1016/j.addr.2016.08.004. Epub 2016 Aug 13. Review.

15.

Functional Delivery of siRNA by Disulfide-Constrained Cyclic Amphipathic Peptides.

Welch JJ, Swanekamp RJ, King C, Dean DA, Nilsson BL.

ACS Med Chem Lett. 2016 Mar 30;7(6):584-9. doi: 10.1021/acsmedchemlett.6b00031. eCollection 2016 Jun 9.

16.

A recombinant chimeric protein specifically induces mutant KRAS degradation and potently inhibits pancreatic tumor growth.

Pan T, Zhang Y, Zhou N, He X, Chen C, Liang L, Duan X, Lin Y, Wu K, Zhang H.

Oncotarget. 2016 Jul 12;7(28):44299-44309. doi: 10.18632/oncotarget.9996.

17.

Functional inhibition of chemokine receptor CCR2 by dicer-substrate-siRNA prevents pain development.

Bégin-Lavallée V, Midavaine É, Dansereau MA, Tétreault P, Longpré JM, Jacobi AM, Rose SD, Behlke MA, Beaudet N, Sarret P.

Mol Pain. 2016 Jun 15;12. pii: 1744806916653969. doi: 10.1177/1744806916653969. Print 2016.

18.

The Late Endosome and Its Lipid BMP Act as Gateways for Efficient Cytosolic Access of the Delivery Agent dfTAT and Its Macromolecular Cargos.

Erazo-Oliveras A, Najjar K, Truong D, Wang TY, Brock DJ, Prater AR, Pellois JP.

Cell Chem Biol. 2016 May 19;23(5):598-607. doi: 10.1016/j.chembiol.2016.03.016. Epub 2016 May 5.

19.

The delivery of therapeutic oligonucleotides.

Juliano RL.

Nucleic Acids Res. 2016 Aug 19;44(14):6518-48. doi: 10.1093/nar/gkw236. Epub 2016 Apr 15. Review.

20.

A Novel p19 Fusion Protein as a Delivery Agent for Short-interfering RNAs.

Danielson DC, Sachrajda N, Wang W, Filip R, Pezacki JP.

Mol Ther Nucleic Acids. 2016 Apr 5;5:e303. doi: 10.1038/mtna.2016.14.

Supplemental Content

Support Center